New imaging technique measures toxicity of proteins associated with Alzheimer’s and Parkinson’s diseases23 Nov 2016
A new super-resolution imaging technique allows researchers to track how surface changes in proteins are related to neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases.
Researchers have discovered a way to remove specific fears from the brain, using a combination of artificial intelligence and brain scanning technology. Their technique, published in the inaugural edition of Nature Human Behaviour, could lead to a new way of treating patients with conditions such as post-traumatic stress disorder (PTSD) and phobias.
The capacity for language is what sets us apart from other animals. Talk with Your Hands, the third of four Cambridge Shorts films, explores the richness of sensory perception in interviews with blind and deaf people together with insights from neuroscientists.
Researchers have identified the first known example of fossilised brain tissue in a dinosaur from Sussex. The tissues resemble those seen in modern crocodiles and birds.
Researchers have identified the cause of chronic, and currently untreatable, pain in those with amputations and severe nerve damage, as well as a potential treatment which relies on engineering instead of drugs.
Rapid advances in neuroscience are driving a huge shift in our understanding of how the brain works and could improve both our cognitive abilities and our brain health, writes Professor Barbara Sahakian (Department of Psychiatry) on The Conversation website.
It's over a hundred years since the first case of Alzheimer’s disease was diagnosed. Since then we’ve learned a great deal about the protein ‘tangles’ and ‘plaques’ that cause the disease. How close are we to having effective treatments – and could we even prevent dementia from occurring in the first place?
Researchers have identified a new mechanism controlling brain development: that neurons not only ‘smell’ chemicals in their environment, but also ‘feel’ their way through the developing brain.
Researchers have identified how alpha-synuclein, the protein associated with Parkinson’s Disease, enables communication between neurons in the brain, offering important clues about what may be happening to patients when the protein malfunctions.